Medtronic plc Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Medtronic plc payments for repurchase of common stock for the quarter ending 2026-07-31 was $267.00M, a 117.07% increase year-over-year.
- Medtronic plc payments for repurchase of common stock for the quarter ending 2026-04-24 was $435.00M, a 58.76% increase year-over-year.
- Medtronic plc payments for repurchase of common stock for the quarter ending 2026-01-23 was $105.00M, a 41.99% decline year-over-year.
- Medtronic plc payments for repurchase of common stock for the quarter ending 2025-10-24 was $372.00M, a 29.17% increase year-over-year.
- Medtronic plc payments for repurchase of common stock for fiscal 2026 was $1.03B, a 68.01% decline from fiscal 2025.
- Medtronic plc payments for repurchase of common stock for fiscal 2025 was $3.23B, a 51.31% increase from fiscal 2024.
- Medtronic plc payments for repurchase of common stock for fiscal 2024 was $2.14B, a 231.47% increase from fiscal 2023.
- Medtronic plc payments for repurchase of common stock for fiscal 2023 was $645.00M, a 74.65% decline from fiscal 2022.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-07-31 | $267.00M 10-Q · filed 2026-09-03 | $1.18B derived: sum of 4 quarters · filed 2026-09-03 |
| 2026-04-24 | $435.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $1.03B 10-K · filed 2026-06-18 |
| 2026-01-23 | $105.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-24 | $874.00M derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-10-24 | $372.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-25 | $950.00M derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-07-25 | $123.00M 10-Q · filed 2026-09-03 | $866.00M derived: sum of 4 quarters · filed 2026-09-03 |
| 2025-04-25 | $274.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $3.23B 10-K · filed 2026-06-18 |
| 2025-01-24 | $181.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-24 | $4.59B derived: sum of 4 quarters · filed 2026-06-18 |
| 2024-10-25 | $288.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-25 | $4.54B derived: sum of 4 quarters · filed 2026-06-18 |
| 2024-07-26 | $2.49B 10-Q · filed 2025-08-26 | $4.48B derived: sum of 4 quarters · filed 2026-06-18 |
| 2024-04-26 | $1.63B derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-18 | $2.14B 10-K · filed 2026-06-18 |
| 2024-01-26 | $132.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-25 | $607.00M derived: sum of 4 quarters · filed 2025-06-20 |
| 2023-10-27 | $226.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-26 | $546.00M derived: sum of 4 quarters · filed 2025-06-20 |
| 2023-07-28 | $152.00M 10-Q · filed 2024-08-27 | $461.00M derived: sum of 4 quarters · filed 2025-06-20 |
| 2023-04-28 | $97.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-20 | $645.00M 10-K · filed 2025-06-20 |
| 2023-01-27 | $71.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-27 | $1.95B derived: sum of 4 quarters · filed 2024-06-20 |
| 2022-10-28 | $141.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-30 | $2.28B derived: sum of 4 quarters · filed 2024-06-20 |
| 2022-07-29 | $336.00M 10-Q · filed 2023-08-31 | $2.56B derived: sum of 4 quarters · filed 2024-06-20 |
| 2022-04-29 | $1.41B derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-20 | $2.54B 10-K · filed 2024-06-20 |
| 2022-01-28 | $394.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-03-01 | $1.71B derived: sum of 4 quarters · filed 2023-06-22 |
| 2021-10-29 | $429.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-12-01 | $1.33B derived: sum of 4 quarters · filed 2023-06-22 |
| 2021-07-30 | $315.00M 10-Q · filed 2022-09-01 | $967.00M derived: sum of 4 quarters · filed 2023-06-22 |
| 2021-04-30 | $575.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22 | $652.00M 10-K · filed 2023-06-22 |
| 2021-01-29 | $9.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-03-03 | $195.00M derived: sum of 4 quarters · filed 2022-06-23 |
| 2020-10-30 | $68.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-12-02 | $432.00M derived: sum of 4 quarters · filed 2022-06-23 |
| 2020-07-31 | $0.00 10-Q · filed 2021-09-02 | $993.00M derived: sum of 4 quarters · filed 2022-06-23 |
| 2020-04-24 | $118.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-23 | $1.33B 10-K · filed 2022-06-23 |
| 2020-01-24 | $246.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-05 | $1.36B derived: sum of 4 quarters · filed 2021-06-25 |
| 2019-10-25 | $629.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-03 | $1.79B derived: sum of 4 quarters · filed 2021-06-25 |
| 2019-07-26 | $333.00M 10-Q · filed 2020-09-03 | $2.39B derived: sum of 4 quarters · filed 2021-06-25 |
| 2019-04-26 | $149.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-25 | $2.88B 10-K · filed 2021-06-25 |
| 2019-01-25 | $681.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-28 | $2.94B derived: sum of 4 quarters · filed 2020-06-19 |
| 2018-10-26 | $1.22B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-03 | $2.33B derived: sum of 4 quarters · filed 2020-06-19 |
| 2018-07-27 | $824.00M 10-Q · filed 2019-08-30 | $1.76B derived: sum of 4 quarters · filed 2020-06-19 |
| 2018-04-27 | $207.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-06-19 | $2.17B 10-K · filed 2020-06-19 |
| 2018-01-26 | $76.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-01 | $2.10B derived: sum of 4 quarters · filed 2019-06-21 |
| 2017-10-27 | $655.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-29 | $2.64B derived: sum of 4 quarters · filed 2019-06-21 |
| 2017-07-28 | $1.23B 10-Q · filed 2018-08-31 | $3.01B derived: sum of 4 quarters · filed 2019-06-21 |
| 2017-04-28 | $135.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-21 | $3.54B 10-K · filed 2019-06-21 |
| 2017-01-27 | $615.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-02 | $4.07B derived: sum of 4 quarters · filed 2018-06-22 |
| 2016-10-28 | $1.03B derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-04 | $4.16B derived: sum of 4 quarters · filed 2018-06-22 |
| 2016-07-29 | $1.76B 10-Q · filed 2017-09-01 | $3.84B derived: sum of 4 quarters · filed 2018-06-22 |
| 2016-04-29 | $660.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-22 | $2.83B 10-K · filed 2018-06-22 |
| 2016-01-29 | $710.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-03-03 | $2.47B derived: sum of 4 quarters · filed 2017-06-27 |
| 2015-10-30 | $710.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-12-05 | $1.76B derived: sum of 4 quarters · filed 2017-06-27 |
| 2015-07-31 | $750.00M 10-Q · filed 2016-09-07 | $1.60B derived: sum of 4 quarters · filed 2017-06-27 |
| 2015-04-24 | $300.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-27 | $1.92B 10-K · filed 2017-06-27 |
| 2015-01-23 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-09 | |
| 2014-10-24 | $555.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-09 | |
| 2014-07-25 | $1.06B 10-Q · filed 2015-09-09 | |
| 2014-04-25 | $2.55B 10-K · filed 2016-06-28 | |
| 2013-04-26 | $1.25B 10-K · filed 2015-06-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B |